X0609 4 2026-05-29 0001091596 Nuo Therapeutics, Inc. AURX 0001674752 Pittman Scott M. false C/O NUO THERAPEUTICS, INC. 8285 EL RIO, SUITE190 HOUSTON TX 77054 1 1 0 Interim Warrant (right to buy) 1.50 2026-05-29 4 A 0 17450 1.50 A 2026-05-29 2031-01-23 Common Stock 17450 17450 D Second Warrant (right to buy) 1.50 2026-05-29 4 D 0 36750 1.50 D 2026-09-30 2031-01-23 Common Stock 36750 0 D Prepayment Warrant (right to buy) 1.50 2026-05-29 4 D 0 7516 1.50 D 2026-01-23 2031-01-23 Common Stock 7516 0 D Second Restated Warrant (right to buy) 1.50 2026-05-29 4 A 0 17500 1.50 A 2026-09-30 2031-01-23 Common Stock 17500 0 D Prepayment Restated Warrant (right to buy) 1.50 2026-05-29 4 A 0 7333 1.50 A 2026-05-29 2031-01-23 Common Stock 7333 0 D Represents Origination Interim and Capital Interim Warrants. Transaction approved by Board of Directors of Issuer and Non-Employee Directors Represents Origination Restated Second and Capital Restated Second Warrants. Previously issued Second Warrants cancelled for Second Restated Warrants with same terms, including same exercise price (and cancelled on date when underlying Common Stock traded at lower price than when previously issued), in accordance with the Amended and Restated Loan and Security Agreement dated May 29, 2026 among the Issuer, the Reporting Person, and other parties thereto (the "Loan Agreement"). Previously issued Prepayment Warrants cancelled for Prepayment Restated Warrants with same terms, including same exercise price (and cancelled on date when underlying Common Stock traded at lower price than when previously issued), in accordance with the Loan Agreement. Vesting (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan Agreement. Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement. Vesting (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2028, in accordance with the Loan Agreement. /s/ David Jorden, attorney-in-fact 2026-06-02